Vivanza Biosci.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE984E01035
NSEID:
BSEID: 530057

INR

2.14

0.00 (0.00%)

BSENSE

Dec 05

BSE+NSE Vol: 2.34 k

{
  "main_header": {
    "sid": 515837,
    "name": "Vivanza Biosci.",
    "stock_name": "Vivanza Biosci.",
    "full_name": "Vivanza Biosciences Ltd",
    "name_url": "stocks-analysis/vivanza-biosci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.14",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "2.14",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530057,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE984E01035",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "2.34 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3744396",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivanzaBioscien_only_sellers_3744396.png",
        "date": "2025-12-03 14:20:20",
        "description": "Vivanza Biosciences Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an order book dominated exclusively by sell orders. This extreme market behaviour signals distress selling and a lack of buyer interest, reflecting a challenging phase for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Why is Vivanza Biosci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vivanza-biosci-fallingrising-3734253",
        "imagepath": "",
        "date": "2025-11-28 00:24:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Trend Reversal</strong></p>\n<p>Vivanza Biosciences’ share price fell by ₹0.12 on 27 November, marking a reversal after four consecutive days of gains. This decline contrasts with the stock’s positive momentum over the past week and month, where it recorded returns of +6.54% and +13.43% respectively. These figures significantly outpace the Sensex’s modest gains of +0.10% over one week and +1.11% over one month, highlighting the stock’s recent relative strength within the market.</p>\n<p>However, despite this short-term outperformance, the stock remains deeply under pressure over longer time horizons. Year-to-date, Vivanza Biosciences has declined by 34.48%, while the Sensex has advanced by 9.70%. Over one year, the stock’s loss widens to 40.63%, compared to the Sensex..."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3733661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3733661.png",
        "date": "2025-11-27 12:25:26",
        "description": "Vivanza Biosciences Ltd is experiencing a pronounced sell-off, marked by a lower circuit scenario with exclusively sell orders dominating the queue. The stock’s performance today reflects severe distress selling, with no buyers stepping in to absorb the pressure, signalling heightened investor concern in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-upper-circuit-amidst-unprecedented-buying-interest-3725378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_buyers_3725378.png",
        "date": "2025-11-24 11:35:27",
        "description": "Vivanza Biosciences Ltd has captured market attention with extraordinary buying momentum, registering a sharp price rise accompanied by an absence of sellers. This rare scenario suggests the stock may sustain its upper circuit status over multiple sessions, reflecting intense demand within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Surges with Unprecedented Buying Interest Amid Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-upper-circuit-amid-unprecedented-buying-interest-3720588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_buyers_3720588.png",
        "date": "2025-11-21 10:35:30",
        "description": "Vivanza Biosciences has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3718442",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3718442.png",
        "date": "2025-11-20 15:25:30",
        "description": "Vivanza Biosciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, marked by a lower circuit scenario with only sell orders in the queue. The stock has recorded consecutive declines over the past four days, signalling distress selling and a lack of buyer interest amid a challenging market environment."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-extreme-selling-pressure-amid-lower-circuit-trigger-3715110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3715110.png",
        "date": "2025-11-19 10:30:47",
        "description": "Vivanza Biosciences Ltd is currently experiencing significant selling pressure, with only sell orders present in the queue today. The stock has recorded a sharp decline of 4.66% in a single day, underperforming the Sensex which posted a modest gain of 0.27%. This distress selling signals heightened investor caution in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Vivanza Biosci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vivanza-biosci-fallingrising-3713008",
        "imagepath": "",
        "date": "2025-11-18 22:29:26",
        "description": "As of 18-Nov, Vivanza Biosciences Ltd is currently priced at 2.36, reflecting a decline of 0.12 or 4.84%. The stock has been underperforming, having lost 9.58% over the last two days and underperformed its sector by 4.21% today. Despite this recent downturn, the stock has shown a positive trend over the past week and month, with returns of 19.19% and 18.59%, respectively. However, it has experienced significant declines year-to-date and over the past year, with losses of 32.18% and 42.16%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 36.86% compared to the five-day average, indicating reduced trading interest.\n\nBroader market context shows that while Vivanza's short-term performance has been strong relative to its recent history, it still lags behind the benchmark Sensex, which has gained 0.96% over the past week and 0.86% over the past month. Th..."
      },
      {
        "title": "Vivanza Biosciences Faces Selling Pressure with 4.84% Decline, Total Loss of 9.58% in Two Days",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-selling-pressure-with-484-decline-total-loss-of-958-in-two-days-3711659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3711659.png",
        "date": "2025-11-18 11:30:42",
        "description": "Vivanza Biosciences Ltd is experiencing significant selling pressure, with a notable decline over the past two days. Despite recent short-term gains, the stock's long-term performance is troubling, showing substantial losses over the past year and three years, contrasting sharply with the Sensex's gains during the same periods."
      }
    ],
    "total": 155,
    "sid": "515837",
    "stock_news_url": "https://www.marketsmojo.com/news/vivanza-biosciences-515837"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby enclose the copies of the postal ballot notice for seeking approval of members of the company the amendementof the Object Clause of the Memorandum of Association (MOA) of the Company as published in the following newspaper: 1. Indian Express in English 2. Financial Express in Gujrati",
      "source": "BSE"
    },
    {
      "caption": "Results - Financial Results For 30Th September 2025",
      "datetime": "14-Nov-2025",
      "details": "Pursuant to regulations 30 & 33 of SEBI (LODR) we inform that the Board at its meeting held on November 11 2025 approved: 1. Un-audited & Standalone Financial results for the quarter ended 3.09.2025 along with a limited review report. 2. Appointment of CS Chaitra Arora (M. No.: A78376) as Company Secretary and Compliance Officer 3. Noted resignation of CS Siddhi Shah (A44885) w.e.f 26.09.2025 4. Alteration of the main object clause of the MOA subject to approvals related disclosure enclosed. 5. Approval of revised Object clause to include activities relating to plastic polymer films packaging material etc. subject to postal ballot approval. 6. Approval of Postal Ballot Calendar Postal Ballot Notice Cut-off date 07-11-2025 and appointment of Scrutinizer Mr. Chintan K. Patel (M. No.: A31987)",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "14-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby submit the postal ballot notice for seeking Members approval for the alteration of the Object Clause of the MOA. The notice has been sent to Members whose names appear in the Register of Members/Beneficial Owners and whose email IDs are registered with the Company/ Depositories as on the cut-off Date 07/11/2025. Members holding Shares in Physical mode who have not registered their email IDs are requested to update the same as per the instructions in the Notice. The Company has Appointed M/s Purva Sharegistry (India) Private Limited for remote e-voting. The e-voting period will be from 9:00 a.m on November 17th 2025 to 5:00 p.m on December 16th 2025after which the E-voting modulke will be diabled",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23",
          "dt": "2023-03-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 14:20:20

Vivanza Biosciences Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an order book dominated exclusively by sell orders. This extreme market behaviour signals distress selling and a lack of buyer interest, reflecting a challenging phase for the pharmaceutical and biotechnology company.

Why is Vivanza Biosci. falling/rising?

2025-11-28 00:24:32

Recent Price Movement and Trend Reversal

Vivanza Biosciences’ share price fell by ₹0.12 on 27 November, marking a reversal after four consecutive days of gains. This decline contrasts with the stock’s positive momentum over the past week and month, where it recorded returns of +6.54% and +13.43% respectively. These figures significantly outpace the Sensex’s modest gains of +0.10% over one week and +1.11% over one month, highlighting the stock’s recent relative strength within the market.

However, despite this short-term outperformance, the stock remains deeply under pressure over longer time horizons. Year-to-date, Vivanza Biosciences has declined by 34.48%, while the Sensex has advanced by 9.70%. Over one year, the stock’s loss widens to 40.63%, compared to the Sensex...

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-27 12:25:26

Vivanza Biosciences Ltd is experiencing a pronounced sell-off, marked by a lower circuit scenario with exclusively sell orders dominating the queue. The stock’s performance today reflects severe distress selling, with no buyers stepping in to absorb the pressure, signalling heightened investor concern in the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit

2025-11-24 11:35:27

Vivanza Biosciences Ltd has captured market attention with extraordinary buying momentum, registering a sharp price rise accompanied by an absence of sellers. This rare scenario suggests the stock may sustain its upper circuit status over multiple sessions, reflecting intense demand within the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Surges with Unprecedented Buying Interest Amid Upper Circuit Lock

2025-11-21 10:35:30

Vivanza Biosciences has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-20 15:25:30

Vivanza Biosciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, marked by a lower circuit scenario with only sell orders in the queue. The stock has recorded consecutive declines over the past four days, signalling distress selling and a lack of buyer interest amid a challenging market environment.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-19 10:30:47

Vivanza Biosciences Ltd is currently experiencing significant selling pressure, with only sell orders present in the queue today. The stock has recorded a sharp decline of 4.66% in a single day, underperforming the Sensex which posted a modest gain of 0.27%. This distress selling signals heightened investor caution in the Pharmaceuticals & Biotechnology sector.

Why is Vivanza Biosci. falling/rising?

2025-11-18 22:29:26

As of 18-Nov, Vivanza Biosciences Ltd is currently priced at 2.36, reflecting a decline of 0.12 or 4.84%. The stock has been underperforming, having lost 9.58% over the last two days and underperformed its sector by 4.21% today. Despite this recent downturn, the stock has shown a positive trend over the past week and month, with returns of 19.19% and 18.59%, respectively. However, it has experienced significant declines year-to-date and over the past year, with losses of 32.18% and 42.16%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 36.86% compared to the five-day average, indicating reduced trading interest. Broader market context shows that while Vivanza's short-term performance has been strong relative to its recent history, it still lags behind the benchmark Sensex, which has gained 0.96% over the past week and 0.86% over the past month. Th...

Vivanza Biosciences Faces Selling Pressure with 4.84% Decline, Total Loss of 9.58% in Two Days

2025-11-18 11:30:42

Vivanza Biosciences Ltd is experiencing significant selling pressure, with a notable decline over the past two days. Despite recent short-term gains, the stock's long-term performance is troubling, showing substantial losses over the past year and three years, contrasting sharply with the Sensex's gains during the same periods.

View All News

Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby enclose the copies of the postal ballot notice for seeking approval of members of the company the amendementof the Object Clause of the Memorandum of Association (MOA) of the Company as published in the following newspaper: 1. Indian Express in English 2. Financial Express in Gujrati

Results - Financial Results For 30Th September 2025

14-Nov-2025 | Source : BSE

Pursuant to regulations 30 & 33 of SEBI (LODR) we inform that the Board at its meeting held on November 11 2025 approved: 1. Un-audited & Standalone Financial results for the quarter ended 3.09.2025 along with a limited review report. 2. Appointment of CS Chaitra Arora (M. No.: A78376) as Company Secretary and Compliance Officer 3. Noted resignation of CS Siddhi Shah (A44885) w.e.f 26.09.2025 4. Alteration of the main object clause of the MOA subject to approvals related disclosure enclosed. 5. Approval of revised Object clause to include activities relating to plastic polymer films packaging material etc. subject to postal ballot approval. 6. Approval of Postal Ballot Calendar Postal Ballot Notice Cut-off date 07-11-2025 and appointment of Scrutinizer Mr. Chintan K. Patel (M. No.: A31987)

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

14-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby submit the postal ballot notice for seeking Members approval for the alteration of the Object Clause of the MOA. The notice has been sent to Members whose names appear in the Register of Members/Beneficial Owners and whose email IDs are registered with the Company/ Depositories as on the cut-off Date 07/11/2025. Members holding Shares in Physical mode who have not registered their email IDs are requested to update the same as per the instructions in the Notice. The Company has Appointed M/s Purva Sharegistry (India) Private Limited for remote e-voting. The e-voting period will be from 9:00 a.m on November 17th 2025 to 5:00 p.m on December 16th 2025after which the E-voting modulke will be diabled